Medicinova has received a new patent license notification for Mn-166 (ibudilast) for the prevention of various solid tumor metastases.
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.